PubMed Health⌕ Search

Biomedical subjects

C Leonardi

Publications and source records attributed to C Leonardi.

At least 19 recordsLinked to original sources

Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasis.

BACKGROUND: Etanercept is a tumour necrosis factor antagonist that is approved in the U.S.A., Canada and Europe for treating adult patients with chronic moderate to severe plaque psoriasis. OBJECTIVES: To assess whether clinical efficacy, safety and pharmacokinetic (PK) profiles of etanercept 50 mg once weekly are comparable to etanercept 25 mg twice weekly. METHODS: Patients from a U.S. phase 3 study and a global phase 3 study were subsequently enrolled in an open-label extension study (extension study) where they all received etanercept at a dose of 50 mg once weekly for an initial 12 weeks. Patients who had received at least 24 weeks of etanercept 25 mg twice weekly in the global phase 3 study and were enrolled in the extension study (n = 265) were assessed for efficacy and safety at extension study baseline and after 12 weeks of etanercept 50 mg once weekly. Efficacy endpoints included the Psoriasis Area and Severity Index (PASI), the Dermatology Life Quality Index and the Physician's Global Assessment of psoriasis. In addition, PK profiles from patients in the U.S. phase 3 study were compared with PK profiles from another set of patients in the extension study. Comparison was made between a subset of patients receiving etanercept 25 mg twice weekly dosing in the U.S. phase 3 study (n = 13) and those receiving etanercept 50 mg once weekly in the extension study (n = 84). RESULTS: The mean PASI score was 5.77 at extension study baseline after treatment with etanercept 25 mg twice weekly, which was sustained at 5.82 after 12 weeks of etanercept 50 mg once weekly. Similar results were observed in other efficacy endpoints. Etanercept 50 mg once weekly was generally well tolerated. No new safety findings were reported. PK profiles overlapped extensively between the two dosing regimens. CONCLUSIONS: In this report, we demonstrate that efficacy, safety and PK profiles were comparable between etanercept 25 mg twice weekly and 50 mg once weekly in patients who had received at least 24 weeks of etanercept 25 mg twice weekly prior to receiving etanercept 50 mg once weekly in the extension study.

Adult↗

A classification of psoriasis vulgaris according to phenotype.

For nearly 200 years it has been appreciated that plaque psoriasis consists of a number of distinct clinical phenotypes. However, a reliable and simple stratification of clinical presentation of psoriasis is lacking. In the era of immunogenetic association studies and an advanced understanding of the pathomechanisms of psoriasis it is important that a classification of the disease according to phenotype is readily available. Such a classification would facilitate clinically relevant interpretation of investigational data. A meeting of the International Psoriasis Council produced a consensus on clinical phenotypes of psoriasis equally relevant to clinical practitioners and psoriasis researchers.

Humans↗

Determination of homovanillic acid (HVA) in human plasma by HPLC with coulometric detection and a new SPE procedure.

A sensitive high-performance liquid chromatographic method has been developed for the determination of homovanillic acid (HVA), the main metabolite of dopamine, in human plasma. Analyses were carried out on a reversed-phase column (C8, 250 mm x 4.6 mm i.d., 5 microm) using a mobile phase composed of 10% methanol and 90% aqueous citrate buffer, containing octanesulfonic acid and EDTA at pH 4.8. Coulometric detection was used, setting the guard cell at +0.100 V, the first analytical cell at -0.200 V and the second analytical cell at +0.500 V. A careful solid-phase extraction procedure, based on strong anion exchange (SAX) cartridges (100 mg, 1 mL), was implemented for the pre-treatment of plasma samples. Extraction yield was satisfactory, being the mean value 98.0%. The calibration curve was linear over the concentration range of 0.2-25.0 ng mL(-1) of homovanillic acid. The limit of quantitation (LOQ) was 0.2 ng mL(-1) and the limit of detection (LOD) was 0.1 ng mL(-1). The method was successfully applied to plasma samples from former alcohol, cocaine and heroin addicts. Results were satisfactory in terms of precision and accuracy. Hence, the method is suitable for the determination of homovanillic acid in human plasma.

Calibration↗

A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis.

OBJECTIVE: To determine the effectiveness and safety of ravuconazole in the treatment of toenail onychomycosis. DESIGN: A phase I/II randomized, double-blind, double-dummy, placebo-controlled, dose-ranging study. Four 12-week dosing regimens were used: 200 mg/day; 100 mg/week; 400 mg/week and placebo. Subjects returned at weeks 2, 4, 6, 8, 10, 12, 14, 16, 24, 36 and 48 for assessment. Subjects were enrolled at 10 dermatology practices (seven in the United States, one in Canada, two in France). SUBJECTS: Adults with distal subungual onychomycosis of one great (hallux) toenail (minimum area of 25%), and at least 2 mm of proximal nail clear of disease were selected. Onychomycosis was confirmed by direct microscopy and/or fungal culture. Subjects with conditions known to produce abnormal-appearing nails were excluded. One hundred and fifty-one subjects were randomized in a 2:2:2:1 ratio to the treatments above. MAIN OUTCOME MEASURES: Primary efficacy was the effective cure rate at week 48 (mycological cure, and clinical cure or > 30% improvement). RESULTS: Effective cure was found in 56% of subjects using 200 mg/day. Effective cure was 10% in subjects receiving 100 mg/week, 8% of subjects using 400 mg/week, and 15% of subjects using placebo. Mycological cure was seen in 59% of subjects in the 200-mg/day group, which was significantly higher than the rates found in the other groups. Drug-related adverse events were infrequent in all treatment arms. Headache was the most frequently reported event. Abnormal laboratory tests were infrequent over the 12 weeks of dosing. Abnormal laboratory findings with increases beyond normal of Grade 2, 3 or 4 were found in 8/148 subjects (5.4%). Only the 200 mg daily regimen had a mean plasma steady state concentration of ravuconazole exceeding the MIC(90) adjusted for 98% protein binding (3000 ng/mL). CONCLUSIONS: For the treatment of onychomycosis, ravuconazole 200 mg/day for 12 weeks is the most effective of the regimens investigated. The safety of all regimens was acceptable. The concentrations of ravuconazole in the plasma compared to the adjusted MIC(90) may be useful in predicting the clinical and mycologic response of therapy.

Administration, Oral↗

Effect of different dietary geometric mean particle length and particle size distribution of oat silage on feeding behavior and productive performance of dairy cattle.

Twenty lactating Holstein cows (5 primiparous and 15 multiparous) were used in a 5 x 5 Latin Square design, with 5 treatments and 3 periods of 21 d each. Diets contained 25% corn silage, 25% oat silage, and 50% concentrate (dry matter basis). The 5 treatments tested in the experiment were long oat silage (LOS), medium oat silage (MOS), fine from long oat silage (FLOS), fine from medium oat silage (FMOS), and half LOS plus half FLOS (LFLOS). The geometric mean particle length (GMPL) of the diets was 6.68, 5.19, 4.46, 4.35, and 5.39 mm for LOS, MOS, FLOS, FMOS, and LFLOS, respectively. The LFLOS was designed to provide dietary GMPL similar to MOS, but with a more bimodal particle size distribution (PSD). Linear and quadratic effects of GMPL were tested, based on the mean GMPL of the feed actually consumed (cGMPL). Contrasts were used to test for the effect of different PSD (MOS vs. LFLOS) and to test for differences between FMOS and FLOS, which would indicate unequal fermentations in the MOS and LOS silos. No differences were detected between FMOS and FLOS in most of the variables measured. Increasing cGMPL linearly decreased dry matter intake, milk production, and milk protein percentage and yield without affecting milk fat percentage, milk fat yield, ruminal pH, and ruminal volatile fatty acid concentration. Although cows fed diets with increasing cGMPL spent more time eating and chewing per day and per kilogram of dry matter intake, there was no effect of cGMPL on rumen pH. Feeding medium oat silage increased milk fat percentage and yield compared with feeding a mixture of long and fine oat silage.

Animals↗

Effect of water addition on selective consumption (sorting) of dry diets by dairy cattle.

The objective of this study was to determine whether adding water to a dry diet would reduce sorting and improve cow performance. Eighteen multiparous lactating Holstein cows were used in a cross-over design with 21-d periods. Treatments had the same dietary composition and differed only by adding water (WET) or not (DRY). Diets consisted of 10% alfalfa silage, 30% hay (approximately 80% grass and 20% alfalfa), and 60% concentrate [dry matter (DM) basis]. Dietary DM was 80.8% for DRY and 64.4% for WET. Both diets contained 16.9% crude protein and 24.3% neutral detergent fiber. Particle size was determined using the Wisconsin Particle Size Separator on the as-fed diets. The separator has five square-hole screens (Y(1) to Y(5)) with diagonal openings of 26.9 mm for Y(1), 18 mm for Y(2), 8.98 mm for Y(3), 5.61 mm for Y(4), and 1.65 mm for Y(5), and one pan. Sorting was calculated on a 60 degrees C DM basis (60DM). Predicted intake of Y(i) was calculated as the product of 60DM intake (60DMI) and the 60DM fraction of Y(i) in the total mixed ration for that screen. For DRY and WET, actual 60DMI by screen expressed as a percentage of predicted intake was 61.4% vs. 75.2% for Y(1), 83.8% vs. 98.6% for Y(2), 85.6% vs. 90.8% for Y(3), 95.2% vs. 96.0% for Y(4), 100.1% vs. 101.9% for Y(5), and 105.9% vs. 102.9% for pan, respectively. Adding water did not affect total DM intake (28.3 kg/d) or milk production (41.3 kg/d). Neutral detergent fiber intake was 6.42 kg/d for WET and 6.15 kg/d for DRY. Milk fat percentage tended to be higher (3.41% vs. 3.31%) when cows consumed WET vs. DRY. No differences in ruminal pH, NH(3), and volatile fatty acids were observed. Cows sorted against long particles in favor of shorter particles on both diets. Adding water to dry diets reduced sorting and tended to increase neutral detergent fiber intake and milk fat percentage.

Animal Feed↗

Effect of increasing oil from distillers grains or corn oil on lactation performance.

The objective of this study was to evaluate production response and more specifically percentage and yield of fat in milk from dairy cows fed distillers grains with added solubles (DGS). It was hypothesized that the oil present in DGS would decrease milk fat yield. Four dietary treatments consisted of dried DGS replacing soybean meal and soybean hulls. The DGS inclusion rates as a percentage of dry matter (DM) were 0, 5, 10, and 15% DGS. To determine the role of oil in DGS, a fifth diet similar to 0% DGS with added corn oil (OIL) was included. Twenty multiparous Holsteins were assigned to a replicated, 5 x 5 Latin Square design with periods of 21 d. Diets were formulated to have similar crude protein and neutral detergent fiber (NDF) concentration. Feeding OIL or 15% DGS resulted in similar production of milk, milk protein, and milk fat. Increasing dietary DGS linearly increased milk production and milk true protein yield. Adding corn oil increased milk yield and, although milk true protein yield also tended to increase with oil, milk true protein concentration decreased. The addition of DGS or OIL did not significantly change fat yield from 0% DGS; however, fat concentration in milk was significantly decreased by DGS due to increased fluid milk production. In diets containing approximately 28% NDF, cottonseed, blood and fish meal, feeding DGS to bring total dietary fatty acids to 5% of diet DM increased milk and milk protein yield without decreasing milk fat yield. Reduced proportions of shorter chain fatty acids and increased proportions of longer chain fatty acids in milk as dietary fatty acid content increased suggests that de novo fatty acid synthesis in the mammary gland was inhibited but this was offset by increased secretion of long-chain fatty acids, presumably absorbed from the diet. Therefore, our hypothesis that feeding corn oil either as DGS or as pure corn oil would decrease milk fat yield was not correct.

Animal Nutritional Physiological Phenomena↗

Effect of domestic cooking on human bioavailability of naringenin, chlorogenic acid, lycopene and beta-carotene in cherry tomatoes.

BACKGROUND: Epidemiological data showed that tomato and tomato product (sauce, paste) consumption is associated with a protective effect against the development of some chronic-degenerative diseases. Tomato antioxidant bioactive molecules such as carotenoids and polyphenols could be responsible, at least in part, for the healthy effect observed. The bioavailability of these compounds is an essential requirement to sustain their in vivo role. While it is well known that many factors can influence the bioaccessibility of carotenoids from the food matrix, there is little information about the factors affecting phenolic compounds' bioaccessibility. AIM OF THE STUDY: This investigation was carried out to evaluate the effect of domestic cooking on the bioavailability in humans of antioxidant molecules after the administration of a test meal containing cherry tomatoes. METHODS: A cross-over design was conducted. Subjects (3 females and 2 males) consumed experimental meals containing fresh and cooked cherry tomatoes. Blood collection was performed at different time intervals (0, 2, 4, 6, 8 and 24 h). RESULTS: Carotenoid and phenol plasma concentrations were measured. Plasma levels of lycopene and beta-carotene were not significantly different with respect to the baseline after ingestion of both the test meals, while plasma concentrations of naringenin and chlorogenic acid increased significantly with respect to the baseline (P<0.05) after administration of cooked cherry tomatoes, but not after administration of fresh cherry tomatoes. CONCLUSIONS: The present study indicated that domestically cooked tomatoes significantly increase naringenin and chlorogenic acid plasma levels. Considering that both naringenin and chlorogenic acid are widely studied for their potential healthy properties, evidence of their bioavailability and of the factors influencing their bioaccessibility is an important tool to sustain the possibility that these polyphenols play a biological role in human physiology.

Adult↗

Effect of quantity, quality, and length of alfalfa hay on selective consumption by dairy cows.

Twenty-four lactating Holstein cows were used in a replicated 6 x 6 Latin square design. Experimental periods were 6 or 7 d. Cows were housed in tie-stalls, and diets were fed ad libitum twice daily at 1100 and 1600 h. Diets contained 60% concentrate and either 40% alfalfa hay or 20% alfalfa hay and 20% alfalfa silage (dry matter basis). The effect of quantity, quality, and length of hay on sorting behavior was determined. Treatments consisted of 20% lower or higher quality long alfalfa hay, 20% lower or higher quality chopped alfalfa hay, and 40% lower or higher quality chopped alfalfa hay. Variation of sorting among cows was also determined. Particle size distribution of samples of as-fed total mixed rations and orts were determined using the Wisconsin particle size separator. Screens have square holes with diagonals of 26.9, 18, 8.98, 5.61, and 1.65 mm (screens Y1 to Y5, respectively). Sorting was calculated as the actual intake of each fraction expressed as a percentage ofthe predicted intake. Increasing the proportion of dry hay increased sorting. Quality of alfalfa hays that were offered did not affect sorting activity. Feeding long alfalfa hay increased selective consumption of fine particles. However, feeding long alfalfa hay also increased intake of longer particles because a higher percentage of long particles was offered. Across treatments, animals consistently sorted against longer particles in favor of finer particles. In particular, intake of Y1 as a percentage of the predicted intake was the most variable. Average Y1 intake, across the six treatments for each cow, was between 60 and 70% of predicted intake for four cows, 71 to 80% for 11 cows, 81 to 90% for five cows, 91 to 100% for two cows, and 101 to 110% for two cows. On one diet a cow failed to consume any of the Y1 portion of the total mixed ration. This variation among animals in sorting of very long feed particles may have practical significance.

Animals↗

Effect of two levels of crude protein and methionine supplementation on performance of dairy cows.

Sixteen Holstein cows in midlactation were randomly assigned to treatments in a replicated 4 x 4 Latin square. Two levels of CP (16.1 vs. 18.8%) with or without supplemental methionine (0.07 g/100 g of DM) were tested in a 2 x 2 factorial arrangement of treatments. Dry matter intake, milk production, milk composition, and N excretion were determined. No interactions between CP level and methionine supplementation were observed. Milk production and dry matter intake were not different among treatments. Milk protein concentration increased from 3.17 to 3.26% with the addition of methionine and decreased from 3.24 to 3.17% with increased CP. No differences were observed among treatments in milk protein yield. Milk fat concentration was low across all diets, but was increased from 2.33% with 16.1% CP diets to 2.68% with 18.8% CP diets. No significant treatment effects were observed for SNF, lactose concentration in milk, or casein N as a fraction of skim milk N. Increased dietary CP increased milk urea N by 3.9 mg/dl. Methionine supplementation did not affect N excretion in urine or feces. The higher protein diets increased estimated urine volume by 2.9 L/d and increased N concentration by 1.7 percentage units in both urine and feces. Feeding higher protein increased milk urea and urine N excretion as expressed as a percentage of total N excreted (44 vs. 38% for 18.8 and 16.1% CP, respectively). Overall, feeding 16.1% CP produced milk and milk protein yields similar to feeding 18.8% CP, but reduced the N losses in urine and milk urea.

Animal Nutritional Physiological Phenomena↗

Night eating syndrome. Preliminary results.

Clinical aspects of the "night eating syndrome" (NES) are described. Recent studies, also referred to in the present report, have revealed certain triggering factors of this syndrome, but do not reveal the nature of the relationship between awakening and compulsory need for food. According to the psychodynamic interpretation, these subjects eat at night to replace dreaming, to which they offer strong resistance, whilst according to the psychobiological interpretation, motivational stimuli develop the irresistible and repeated desire for food. Within a post-rational cognitive theoretical model, the compulsion to food would be the mode through which subjects obtain a modified conscious state necessary to appease the suffering due to an experience of emptiness and incapacity. Psychological support associated with pharmacological treatment (benzodiazepine, gamma-hydroxybutyric acid) has been shown, in a personal series, to be effective both upon the sleep disorder and craving.

Adult↗

Antioxidative activity and carotenoid and tomatine contents in different typologies of fresh consumption tomatoes.

The phytonutrient intake associated with tomato consumption depends also on cultivar and fruit ripening stage. This work associates the antioxidative ability, the level of carotenoids, and the amount of glycoalkaloids to the main carpometric characteristics of four different typologies of tomatoes: "cherry", "cluster", "elongated," and "salad". These typologies have different weights and shapes, and they are usually consumed in the Mediterranean area at different ripening stages. Results showed that the considered tomato typologies also differ in their antioxidative ability and their carotenoid and glycoalkaloid contents. Growing conditions are also important in determining fruit characteristics: the analysis of the same cultivar of cherry tomato produced under the influence of moderate salt stress showed increases in the lipophilic antioxidative ability and the amount of carotenoid, whereas the level of glycoalkaloid decreased.

Antioxidants↗

The antiinflammatory cytokine interleukin-13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta1b treatment, that neither modifies its ex vivo secretion from peripheral blood mononuclear cells.

Interleukin (IL)-13 is a T-cell derived cytokine closely related to IL-4 that possesses powerful antiinflammatory properties. In this study we have evaluated the blood levels of IL-13 in patients with multiple sclerosis (MS), either with relapsing remitting or secondary chronic progressive (CP) course of the disease, and have also examined the effect of treatment with interferon (IFN)-beta 1b given on alternate days for 10 days both on the serum levels of IL-13 and on the ex vivo secretory capacity of mononuclear cells from MS patients. IL-13 was not detectable in the circulation of MS patients regardless of whether RR MS patients with stable or active disease or those suffering from secondary CP MS were studied. Moreover, circulating levels of IL-13 were not induced by treatment with IFN- beta1b, that was neither capable of modifying the ex vivo IL-13 secretory capacity of peripheral blood mononuclear cells. These data neither anticipate a role for endogenous IL-13 in down-regulating immunoinflammation during MS attacks nor suggest that IFN-betalb treatment exerts its favourable effects on the course of RR MS by augmenting the secretion of this antiinflammatory cytokine.

Adult↗

Clinical reactogenicity of intradermal bacille Calmette-Guérin vaccination.

Clinical, microbiological, and immunologic responses were evaluated in volunteers vaccinated intradermally with bacille Calmette-Guérin (BCG). Most volunteers (98%) developed ulcerative lesions that drained for a mean +/- SE of 4.3 +/- 0.29 weeks. Mycobacterial DNA was detected by a polymerase chain reaction-based amplification technique in biopsy specimens from BCG ulcers 2 weeks after vaccination and in blood specimens 3 days after vaccination. Mycobacteria were cultured from ulcer drainage 2 months after vaccination, demonstrating a prolonged potential risk of contact spread of the vaccine strain. The duration of ulcer drainage was inversely correlated with prevaccination lymphoproliferative (r = -0.515; P < .002) and interferon gamma (r = -0.841; P < .002) responses specific to mycobacteria and directly correlated with postvaccination increases in lymphoproliferative (r = 0.498; P < .002) and interferon gamma (r = 0.688; P < .02) responses specific to mycobacteria. These results demonstrate the clinical reactogenicity of BCG and the potential risk of contact spread of the vaccine strain and suggest that clinical reactogenicity is a trade-off for the induction of protective mycobacterial immunity.

Adolescent↗

Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency.

One single intra-venous (i.v.) injection of Concanavalin A (Con A) into mice provokes a cell-mediated immunoinflammatory hepatitis. We have presently evaluated the immunopharmacological effects of exogenous interleukin (IL)-10 and the role of endogenous IL-10 in this model by using exogenous IL-10, anti-IL-10 monoclonal antibody (mAb) and mice with disrupted IL-10 gene (IL-10 KO mice). Whilst exogenous IL-10 administered in a prophylactic (1 h prior to Con A) and even "early" therapeutic fashion (30 min after Con A) reduced the elevation of transaminase activities in plasma in a dose-dependent manner, observed in control mice, these biochemical markers of liver injury were significantly increased both in IL-10 KO mice as well as in those receiving anti-IL-10 mAb. Interestingly, doses of Con A lower than 20 mg/kg that were only capable of inducing slight serological signs of hepatitis in mice, exerted marked hepatitic effects when administered to either anti-IL-10 mAb-treated mice or to IL-10 KO mice. The disease modulating effects of exogenous IL-10 and either genetical or pharmacologically-induced IL-10 deficiency were associated with profound and opposite modifications of the Con A-induced increase in the circulating levels of IFN-gamma and TNF-alpha. Relative to control animals, the blood levels of these cytokines were diminished in IL-10-treated mice and augmented in both IL-10 KO mice and anti-IL-10 mAb-treated mice. These results prove the physiological antiinflammatory role of endogenous IL-10 in Con A induced hepatitis and the beneficial effects of IL-10 treatment to prevent this condition.

Alanine Transaminase↗

Deoxyspergualin neither counteracts lipopolysaccharide (LPS) or Staphylococcus aureus enterotoxin-B (SEB) induced lethality in mice nor does it modulate the release of tumor necrosis factor-alpha.

To gain further insights into the immunopharmacological mode of action of the immunosuppressant antibiotic deoxyspergualin (DSP), its effects were evaluated in murine lethal endo- and exotoxemia. These are two cytokine-mediated macrophage and T cell dependent immunoinflammatory conditions that can be induced in D-Galactosamine (D-Gal) presensitized mice by the injections with either LPS or SEB, respectively. The results show that prophylactic treatment with DSP (2.5 or 5 mg/kg bd.wt. 48, 24 and 2 h prior to challenge) neither improved the rate of survival, nor influenced the massive increase in the blood levels of tumor necrosis factor-alpha which followed the challenge with LPS or SEB. In sharp contrast, these clinical and seroimmunological events were both markedly counteracted by prophylactic treatment with sodium fusidate, another immunosuppressive agent used as control.

Animals↗

Diagnosis and treatment of a case of cutaneous cytomegalovirus infection with a dramatic clinical presentation.

A patient receiving long-term immunosuppressive treatment of systemic lupus erythematosus developed multiple large painful ulcers on her upper body. Histologic analysis showed cytopathic changes typical of cytomegalovirus infection that was confirmed by immunoperoxidase staining and polymerase chain reaction analyses. Treatment with ganciclovir and foscarnet resulted in clinical resolution. No recurrence was evident 6 months later.

Adult↗